pubmed-article:16982322 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16982322 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:16982322 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
pubmed-article:16982322 | lifeskim:mentions | umls-concept:C0026764 | lld:lifeskim |
pubmed-article:16982322 | lifeskim:mentions | umls-concept:C0079459 | lld:lifeskim |
pubmed-article:16982322 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
pubmed-article:16982322 | lifeskim:mentions | umls-concept:C0005767 | lld:lifeskim |
pubmed-article:16982322 | lifeskim:mentions | umls-concept:C0027950 | lld:lifeskim |
pubmed-article:16982322 | lifeskim:mentions | umls-concept:C1504389 | lld:lifeskim |
pubmed-article:16982322 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
pubmed-article:16982322 | lifeskim:mentions | umls-concept:C1136535 | lld:lifeskim |
pubmed-article:16982322 | lifeskim:mentions | umls-concept:C0439859 | lld:lifeskim |
pubmed-article:16982322 | lifeskim:mentions | umls-concept:C1328050 | lld:lifeskim |
pubmed-article:16982322 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:16982322 | pubmed:dateCreated | 2006-9-19 | lld:pubmed |
pubmed-article:16982322 | pubmed:abstractText | Pegfilgrastim has shown to decrease the duration of severe neutropenia after conventional chemotherapy, but its use after high-dose chemotherapy and autologous blood stem cell transplantation has not been established yet. Therefore we studied the efficacy and the pharmacokinetic profile of pegfilgrastim in patients with multiple myeloma undergoing high-dose chemotherapy. | lld:pubmed |
pubmed-article:16982322 | pubmed:language | eng | lld:pubmed |
pubmed-article:16982322 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16982322 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16982322 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16982322 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16982322 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16982322 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16982322 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16982322 | pubmed:month | Oct | lld:pubmed |
pubmed-article:16982322 | pubmed:issn | 0301-472X | lld:pubmed |
pubmed-article:16982322 | pubmed:author | pubmed-author:HaasRainerR | lld:pubmed |
pubmed-article:16982322 | pubmed:author | pubmed-author:SteidlUlrichU | lld:pubmed |
pubmed-article:16982322 | pubmed:author | pubmed-author:FenkRolandR | lld:pubmed |
pubmed-article:16982322 | pubmed:author | pubmed-author:KobbeGuidoG | lld:pubmed |
pubmed-article:16982322 | pubmed:author | pubmed-author:ZohrenFabianF | lld:pubmed |
pubmed-article:16982322 | pubmed:author | pubmed-author:BrunsIngmarI | lld:pubmed |
pubmed-article:16982322 | pubmed:author | pubmed-author:GraefThorsten... | lld:pubmed |
pubmed-article:16982322 | pubmed:author | pubmed-author:RufLeilaniL | lld:pubmed |
pubmed-article:16982322 | pubmed:author | pubmed-author:HieronimusNad... | lld:pubmed |
pubmed-article:16982322 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16982322 | pubmed:volume | 34 | lld:pubmed |
pubmed-article:16982322 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16982322 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16982322 | pubmed:pagination | 1296-302 | lld:pubmed |
pubmed-article:16982322 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:16982322 | pubmed:meshHeading | pubmed-meshheading:16982322... | lld:pubmed |
pubmed-article:16982322 | pubmed:meshHeading | pubmed-meshheading:16982322... | lld:pubmed |
pubmed-article:16982322 | pubmed:meshHeading | pubmed-meshheading:16982322... | lld:pubmed |
pubmed-article:16982322 | pubmed:meshHeading | pubmed-meshheading:16982322... | lld:pubmed |
pubmed-article:16982322 | pubmed:meshHeading | pubmed-meshheading:16982322... | lld:pubmed |
pubmed-article:16982322 | pubmed:meshHeading | pubmed-meshheading:16982322... | lld:pubmed |
pubmed-article:16982322 | pubmed:meshHeading | pubmed-meshheading:16982322... | lld:pubmed |
pubmed-article:16982322 | pubmed:meshHeading | pubmed-meshheading:16982322... | lld:pubmed |
pubmed-article:16982322 | pubmed:meshHeading | pubmed-meshheading:16982322... | lld:pubmed |
pubmed-article:16982322 | pubmed:meshHeading | pubmed-meshheading:16982322... | lld:pubmed |
pubmed-article:16982322 | pubmed:meshHeading | pubmed-meshheading:16982322... | lld:pubmed |
pubmed-article:16982322 | pubmed:meshHeading | pubmed-meshheading:16982322... | lld:pubmed |
pubmed-article:16982322 | pubmed:meshHeading | pubmed-meshheading:16982322... | lld:pubmed |
pubmed-article:16982322 | pubmed:meshHeading | pubmed-meshheading:16982322... | lld:pubmed |
pubmed-article:16982322 | pubmed:meshHeading | pubmed-meshheading:16982322... | lld:pubmed |
pubmed-article:16982322 | pubmed:meshHeading | pubmed-meshheading:16982322... | lld:pubmed |
pubmed-article:16982322 | pubmed:meshHeading | pubmed-meshheading:16982322... | lld:pubmed |
pubmed-article:16982322 | pubmed:meshHeading | pubmed-meshheading:16982322... | lld:pubmed |
pubmed-article:16982322 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16982322 | pubmed:articleTitle | Sustained G-CSF plasma levels following administration of pegfilgrastim fasten neutrophil reconstitution after high-dose chemotherapy and autologous blood stem cell transplantation in patients with multiple myeloma. | lld:pubmed |
pubmed-article:16982322 | pubmed:affiliation | Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, Duesseldorf, Germany. | lld:pubmed |
pubmed-article:16982322 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16982322 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:16982322 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |